Cardinal Health, Inc. (LON:0HTG)
London
· Delayed Price · Currency is GBP · Price in USD 148.61
+0.54 (0.36%)
At close: May 13, 2025
Revenue by Product
Fiscal year is July - June.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Pharmaceutical and Specialty Solutions | 204.88B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical and Specialty Solutions Growth | 0.54% |
Log In |
Log In |
Log In |
Log In |
| Global Medical Products and Distribution | 12.55B |
Log In |
Log In |
Log In |
Log In |
| Global Medical Products and Distribution Growth | 1.84% |
Log In |
Log In |
Log In |
Log In |
| Other Segment | 4.95B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Growth | 13.42% |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Segment | - |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Segment Growth | - |
Log In |
Log In |
Log In |
Log In |
| Medical Segment | - |
Log In |
Log In |
Log In |
Log In |
| Medical Segment Growth | - |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Distribution and Specialty Solutions | - |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Distribution and Specialty Solutions Growth | - |
Log In |
Log In |
Log In |
Log In |
| Nuclear and Precision Health Solutions | - |
Log In |
Log In |
Log In |
Log In |
| Nuclear and Precision Health Solutions Growth | - |
Log In |
Log In |
Log In |
Log In |
| Medical Distribution and Products | - |
Log In |
Log In |
Log In |
Log In |
| Medical Distribution and Products Growth | - |
Log In |
Log In |
Log In |
Log In |
| Cardinal Health at-Home Solutions | - |
Log In |
Log In |
Log In |
Log In |
| Cardinal Health at-Home Solutions Growth | - |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is July - June.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Pharmaceutical and Specialty Solutions Segment Profit | 2.21B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical and Specialty Solutions Segment Profit Growth | 11.31% |
Log In |
Log In |
Log In |
Log In |
| Global Medical Products and Distribution Segment Profit | 112.00M |
Log In |
Log In |
Log In |
Log In |
| Global Medical Products and Distribution Segment Profit Growth | 115.38% |
Log In |
Log In |
Log In |
Log In |
| Other Segment Segment Profit | 467.00M |
Log In |
Log In |
Log In |
Log In |
| Other Segment Segment Profit Growth | 13.35% |
Log In |
Log In |
Log In |
Log In |
| Corporate Profit | -541.00M |
Log In |
Log In |
Log In |
Log In |
| Corporate Profit Growth | -63.86% |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Segment Profit | - |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
| Medical Segment Profit | - |
Log In |
Log In |
Log In |
Log In |
| Medical Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is July - June.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| United States | 222.97B |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 0.87% |
Log In |
Log In |
Log In |
Log In |
| International | -716.00M |
Log In |
Log In |
Log In |
Log In |
| International Growth | 24.52% |
Log In |
Log In |
Log In |
Log In |